A multi-center, randomized, double-blind study to compare the efficacy and safety of cadazolid versus vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD)

Multizentrische, prospektive Kohortenstudie zu Mikrobiota-definierten und klinischen Risikofaktoren für eine Kolonisierung mit Clostridium difficile und -assoziierte Erkrankung (CDAD) in Risikokollektiven (Cadazolid /ACT-179811 (AC-0641A301))

A phase IIIb/IV randomized, controlled, open label, parallel group study to compare the efficacy of vancomycin therapy to extended duration fidaxomicin therapy in the sustained clinical cure of Clostridium difficile Infection in an older population (EXTEND)

A Randomized, Double-Blinded, Active-Controlled Study of Surotomycin (CB-183,315) in Patients with Clostridium difficile Associated Diarrhea

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to Clostridium difficile toxin B), and MK-3415A (Human Monoclonal Antibodies to Clostridium difficile toxin A and toxin B) in Patients Receiving Antibiotic Therapy for Clostridium difficile Infection (MODIFY I)